ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Omics Based Clinical Trials Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-22N10214
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Omics Based Clinical Trials Market Research Report 2022
BUY CHAPTERS

Global Omics Based Clinical Trials Market Research Report 2025

Code: QYRE-Auto-22N10214
Report
March 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PAREXEL International Corporation
Pharmaceutical Product Development (PPD)
Charles River Laboratory
ICON
SGS SA
Eli Lilly and Company
Pfizer Inc
Covance
Novo Nordisk
Rebus Bio

Omics Based Clinical Trials Market Size

The global market for Omics Based Clinical Trials was valued at US$ 2244 million in the year 2024 and is projected to reach a revised size of US$ 3268 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Omics Based Clinical Trials Market

Omics Based Clinical Trials Market

Omics is a rapidly evolving, multi-disciplinary, and emerging field that encompasses genomics, epigenomics, transcriptomics, proteomics, and metabolomics.Advanced omics technologies, including single-cell omics and multi-omics, are being used to evaluate a variety of cancer immunotherapies. Furthermore, given the precision medicine environment, the expanding use of multi-omics in research, as well as the penetration of contemporary sequencing technologies, is boosting the market.
Omics is a rapidly evolving, multi-disciplinary, and emerging field that encompasses genomics, epigenomics, transcriptomics, proteomics, and metabolomics.Advanced omics technologies, including single-cell omics and multi-omics, are being used to evaluate a variety of cancer immunotherapies. Furthermore, given the precision medicine environment, the expanding use of multi-omics in research, as well as the penetration of contemporary sequencing technologies, is boosting the market.
This report aims to provide a comprehensive presentation of the global market for Omics Based Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omics Based Clinical Trials.
The Omics Based Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Omics Based Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Omics Based Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Omics Based Clinical Trials Market Report

Report Metric Details
Report Name Omics Based Clinical Trials Market
Accounted market size in year US$ 2244 million
Forecasted market size in 2031 US$ 3268 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Oncology
  • Cardiology
  • Respiratory Diseases
  • Skin Diseases
  • CNS Diseases
  • Immunology
  • Genetic Diseases
  • Other Indications
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer, Covance, Rebus Bio, Novo Nordisk
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Omics Based Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Omics Based Clinical Trials Market growing?

Ans: The Omics Based Clinical Trials Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Omics Based Clinical Trials Market size in 2031?

Ans: The Omics Based Clinical Trials Market size in 2031 will be US$ 3268 million.

Who are the main players in the Omics Based Clinical Trials Market report?

Ans: The main players in the Omics Based Clinical Trials Market are Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer, Covance, Rebus Bio, Novo Nordisk

What are the Application segmentation covered in the Omics Based Clinical Trials Market report?

Ans: The Applications covered in the Omics Based Clinical Trials Market report are Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, Other Indications

What are the Type segmentation covered in the Omics Based Clinical Trials Market report?

Ans: The Types covered in the Omics Based Clinical Trials Market report are Interventional Studies, Observational Studies, Expanded Access Studies

Recommended Reports

Cancer Diagnostics & Therapy

Precision Medicine

Clinical Trials & Outsourcing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Omics Based Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Interventional Studies
1.2.3 Observational Studies
1.2.4 Expanded Access Studies
1.3 Market by Application
1.3.1 Global Omics Based Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Respiratory Diseases
1.3.5 Skin Diseases
1.3.6 CNS Diseases
1.3.7 Immunology
1.3.8 Genetic Diseases
1.3.9 Other Indications
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Omics Based Clinical Trials Market Perspective (2020-2031)
2.2 Global Omics Based Clinical Trials Growth Trends by Region
2.2.1 Global Omics Based Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Omics Based Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 Omics Based Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 Omics Based Clinical Trials Market Dynamics
2.3.1 Omics Based Clinical Trials Industry Trends
2.3.2 Omics Based Clinical Trials Market Drivers
2.3.3 Omics Based Clinical Trials Market Challenges
2.3.4 Omics Based Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Omics Based Clinical Trials Players by Revenue
3.1.1 Global Top Omics Based Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global Omics Based Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global Omics Based Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Omics Based Clinical Trials Revenue
3.4 Global Omics Based Clinical Trials Market Concentration Ratio
3.4.1 Global Omics Based Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Omics Based Clinical Trials Revenue in 2024
3.5 Global Key Players of Omics Based Clinical Trials Head office and Area Served
3.6 Global Key Players of Omics Based Clinical Trials, Product and Application
3.7 Global Key Players of Omics Based Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Omics Based Clinical Trials Breakdown Data by Type
4.1 Global Omics Based Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global Omics Based Clinical Trials Forecasted Market Size by Type (2026-2031)
5 Omics Based Clinical Trials Breakdown Data by Application
5.1 Global Omics Based Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global Omics Based Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Omics Based Clinical Trials Market Size (2020-2031)
6.2 North America Omics Based Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Omics Based Clinical Trials Market Size by Country (2020-2025)
6.4 North America Omics Based Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Omics Based Clinical Trials Market Size (2020-2031)
7.2 Europe Omics Based Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Omics Based Clinical Trials Market Size by Country (2020-2025)
7.4 Europe Omics Based Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Omics Based Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific Omics Based Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Omics Based Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific Omics Based Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Omics Based Clinical Trials Market Size (2020-2031)
9.2 Latin America Omics Based Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Omics Based Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America Omics Based Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Omics Based Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa Omics Based Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Omics Based Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa Omics Based Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Parexel International Corporation
11.1.1 Parexel International Corporation Company Details
11.1.2 Parexel International Corporation Business Overview
11.1.3 Parexel International Corporation Omics Based Clinical Trials Introduction
11.1.4 Parexel International Corporation Revenue in Omics Based Clinical Trials Business (2020-2025)
11.1.5 Parexel International Corporation Recent Development
11.2 Pharmaceutical Product Development (PPD)
11.2.1 Pharmaceutical Product Development (PPD) Company Details
11.2.2 Pharmaceutical Product Development (PPD) Business Overview
11.2.3 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Introduction
11.2.4 Pharmaceutical Product Development (PPD) Revenue in Omics Based Clinical Trials Business (2020-2025)
11.2.5 Pharmaceutical Product Development (PPD) Recent Development
11.3 Charles River Laboratory
11.3.1 Charles River Laboratory Company Details
11.3.2 Charles River Laboratory Business Overview
11.3.3 Charles River Laboratory Omics Based Clinical Trials Introduction
11.3.4 Charles River Laboratory Revenue in Omics Based Clinical Trials Business (2020-2025)
11.3.5 Charles River Laboratory Recent Development
11.4 ICON plc
11.4.1 ICON plc Company Details
11.4.2 ICON plc Business Overview
11.4.3 ICON plc Omics Based Clinical Trials Introduction
11.4.4 ICON plc Revenue in Omics Based Clinical Trials Business (2020-2025)
11.4.5 ICON plc Recent Development
11.5 SGS SA
11.5.1 SGS SA Company Details
11.5.2 SGS SA Business Overview
11.5.3 SGS SA Omics Based Clinical Trials Introduction
11.5.4 SGS SA Revenue in Omics Based Clinical Trials Business (2020-2025)
11.5.5 SGS SA Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Omics Based Clinical Trials Introduction
11.6.4 Eli Lilly and Company Revenue in Omics Based Clinical Trials Business (2020-2025)
11.6.5 Eli Lilly and Company Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Omics Based Clinical Trials Introduction
11.7.4 Pfizer Revenue in Omics Based Clinical Trials Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Covance
11.8.1 Covance Company Details
11.8.2 Covance Business Overview
11.8.3 Covance Omics Based Clinical Trials Introduction
11.8.4 Covance Revenue in Omics Based Clinical Trials Business (2020-2025)
11.8.5 Covance Recent Development
11.9 Rebus Bio
11.9.1 Rebus Bio Company Details
11.9.2 Rebus Bio Business Overview
11.9.3 Rebus Bio Omics Based Clinical Trials Introduction
11.9.4 Rebus Bio Revenue in Omics Based Clinical Trials Business (2020-2025)
11.9.5 Rebus Bio Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Omics Based Clinical Trials Introduction
11.10.4 Novo Nordisk Revenue in Omics Based Clinical Trials Business (2020-2025)
11.10.5 Novo Nordisk Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
PAREXEL International Corporation
Pharmaceutical Product Development (PPD)
Charles River Laboratory
ICON
SGS SA
Eli Lilly and Company
Pfizer Inc
Covance
Novo Nordisk
Rebus Bio
List of Tables
 Table 1. Global Omics Based Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Interventional Studies
 Table 3. Key Players of Observational Studies
 Table 4. Key Players of Expanded Access Studies
 Table 5. Global Omics Based Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Omics Based Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Omics Based Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Omics Based Clinical Trials Market Share by Region (2020-2025)
 Table 9. Global Omics Based Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Omics Based Clinical Trials Market Share by Region (2026-2031)
 Table 11. Omics Based Clinical Trials Market Trends
 Table 12. Omics Based Clinical Trials Market Drivers
 Table 13. Omics Based Clinical Trials Market Challenges
 Table 14. Omics Based Clinical Trials Market Restraints
 Table 15. Global Omics Based Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Omics Based Clinical Trials Market Share by Players (2020-2025)
 Table 17. Global Top Omics Based Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omics Based Clinical Trials as of 2024)
 Table 18. Ranking of Global Top Omics Based Clinical Trials Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Omics Based Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Omics Based Clinical Trials, Headquarters and Area Served
 Table 21. Global Key Players of Omics Based Clinical Trials, Product and Application
 Table 22. Global Key Players of Omics Based Clinical Trials, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Omics Based Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Omics Based Clinical Trials Revenue Market Share by Type (2020-2025)
 Table 26. Global Omics Based Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Omics Based Clinical Trials Revenue Market Share by Type (2026-2031)
 Table 28. Global Omics Based Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Omics Based Clinical Trials Revenue Market Share by Application (2020-2025)
 Table 30. Global Omics Based Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Omics Based Clinical Trials Revenue Market Share by Application (2026-2031)
 Table 32. North America Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Omics Based Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Omics Based Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Omics Based Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Omics Based Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Omics Based Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Omics Based Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Omics Based Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Omics Based Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Omics Based Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Omics Based Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Omics Based Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Parexel International Corporation Company Details
 Table 48. Parexel International Corporation Business Overview
 Table 49. Parexel International Corporation Omics Based Clinical Trials Product
 Table 50. Parexel International Corporation Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 51. Parexel International Corporation Recent Development
 Table 52. Pharmaceutical Product Development (PPD) Company Details
 Table 53. Pharmaceutical Product Development (PPD) Business Overview
 Table 54. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Product
 Table 55. Pharmaceutical Product Development (PPD) Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 56. Pharmaceutical Product Development (PPD) Recent Development
 Table 57. Charles River Laboratory Company Details
 Table 58. Charles River Laboratory Business Overview
 Table 59. Charles River Laboratory Omics Based Clinical Trials Product
 Table 60. Charles River Laboratory Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 61. Charles River Laboratory Recent Development
 Table 62. ICON plc Company Details
 Table 63. ICON plc Business Overview
 Table 64. ICON plc Omics Based Clinical Trials Product
 Table 65. ICON plc Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 66. ICON plc Recent Development
 Table 67. SGS SA Company Details
 Table 68. SGS SA Business Overview
 Table 69. SGS SA Omics Based Clinical Trials Product
 Table 70. SGS SA Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 71. SGS SA Recent Development
 Table 72. Eli Lilly and Company Company Details
 Table 73. Eli Lilly and Company Business Overview
 Table 74. Eli Lilly and Company Omics Based Clinical Trials Product
 Table 75. Eli Lilly and Company Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 76. Eli Lilly and Company Recent Development
 Table 77. Pfizer Company Details
 Table 78. Pfizer Business Overview
 Table 79. Pfizer Omics Based Clinical Trials Product
 Table 80. Pfizer Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 81. Pfizer Recent Development
 Table 82. Covance Company Details
 Table 83. Covance Business Overview
 Table 84. Covance Omics Based Clinical Trials Product
 Table 85. Covance Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 86. Covance Recent Development
 Table 87. Rebus Bio Company Details
 Table 88. Rebus Bio Business Overview
 Table 89. Rebus Bio Omics Based Clinical Trials Product
 Table 90. Rebus Bio Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 91. Rebus Bio Recent Development
 Table 92. Novo Nordisk Company Details
 Table 93. Novo Nordisk Business Overview
 Table 94. Novo Nordisk Omics Based Clinical Trials Product
 Table 95. Novo Nordisk Revenue in Omics Based Clinical Trials Business (2020-2025) & (US$ Million)
 Table 96. Novo Nordisk Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Omics Based Clinical Trials Picture
 Figure 2. Global Omics Based Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Omics Based Clinical Trials Market Share by Type: 2024 VS 2031
 Figure 4. Interventional Studies Features
 Figure 5. Observational Studies Features
 Figure 6. Expanded Access Studies Features
 Figure 7. Global Omics Based Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Omics Based Clinical Trials Market Share by Application: 2024 VS 2031
 Figure 9. Oncology Case Studies
 Figure 10. Cardiology Case Studies
 Figure 11. Respiratory Diseases Case Studies
 Figure 12. Skin Diseases Case Studies
 Figure 13. CNS Diseases Case Studies
 Figure 14. Immunology Case Studies
 Figure 15. Genetic Diseases Case Studies
 Figure 16. Other Indications Case Studies
 Figure 17. Omics Based Clinical Trials Report Years Considered
 Figure 18. Global Omics Based Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Omics Based Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Omics Based Clinical Trials Market Share by Region: 2024 VS 2031
 Figure 21. Global Omics Based Clinical Trials Market Share by Players in 2024
 Figure 22. Global Top Omics Based Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omics Based Clinical Trials as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Omics Based Clinical Trials Revenue in 2024
 Figure 24. North America Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Omics Based Clinical Trials Market Share by Country (2020-2031)
 Figure 26. United States Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Omics Based Clinical Trials Market Share by Country (2020-2031)
 Figure 30. Germany Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Omics Based Clinical Trials Market Share by Region (2020-2031)
 Figure 38. China Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Omics Based Clinical Trials Market Share by Country (2020-2031)
 Figure 46. Mexico Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Omics Based Clinical Trials Market Share by Country (2020-2031)
 Figure 50. Turkey Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Omics Based Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Parexel International Corporation Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 54. Pharmaceutical Product Development (PPD) Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 55. Charles River Laboratory Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 56. ICON plc Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 57. SGS SA Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 58. Eli Lilly and Company Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 59. Pfizer Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 60. Covance Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 61. Rebus Bio Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 62. Novo Nordisk Revenue Growth Rate in Omics Based Clinical Trials Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Multiomics Market Research Report 2024
Global Spatial Multi Omics Solution Market Research Report 2024
Global Human Single Cell Multi Omics Market Research Report 2024
Global Spatial Omics Market Research Report 2024
Transcriptome Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epigenome Analysis Market Research Report 2025
Global Microbiome Sample Preparation Technology Market Research Report 2024
Global Clinical Next Generation Sequencing Market Insights Forecast to 2030
Cloud Computing in Cell Biology Genomics and Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno oncology Clinical Trials Market Research Report 2024
next generation sequencing sample preparation market
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Global Patient Engagement Services Market Insights Forecast to 2030
Global Agricultural Genome Market Insights Forecast to 2030
Global Genomic Data Analysis Service Market Research Report 2025
Single Cell Multiomics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Clinical Trial Market Research Report 2024
Mammalian Single Cell Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI for Pharma and Biotech Market Insights Forecast to 2030
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions